Literature DB >> 27462388

Psoriasiform Sarcoidosis: Collision of Two Entities or Expression of One Common Pathogenesis?

Miriam L Vega1, Jennifer Abrahams2, Matthew Keller1.   

Abstract

BACKGROUND: Psoriasiform lesions are an established, but rare, manifestation of sarcoidosis. Only 0.9 percent of patients with cutaneous sarcoidosis develop this form of the disease. OBSERVATION: The authors present a case of a 61-year-old woman with a history of pulmonary sarcoidosis who presented to their dermatology clinic with thick plaques resembling psoriasis. Biopsy of one of the lesions revealed sarcoidal granulomas in association with psoriasiform changes.
CONCLUSION: Psoriasiform lesions are a rare manifestation of sarcoidosis. The authors theorize that the co-expression of TNF-α in both entities is a possible explanation of the psoriasiform expression of sarcoidosis.

Entities:  

Year:  2016        PMID: 27462388      PMCID: PMC4898586     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  16 in total

1.  Infliximab for refractory sarcoidosis.

Authors:  R P Baughman; E E Lower
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2001-03       Impact factor: 0.670

Review 2.  TNF-alpha and apoptosis: implications for the pathogenesis and treatment of psoriasis.

Authors:  Frank C Victor; Alice B Gottlieb
Journal:  J Drugs Dermatol       Date:  2002-12       Impact factor: 2.114

Review 3.  Evidence-based therapy for cutaneous sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Clin Dermatol       Date:  2007 May-Jun       Impact factor: 3.541

4.  Treatment of therapy-resistant sarcoidosis with adalimumab.

Authors:  José Luis Callejas-Rubio; Norberto Ortego-Centeno; Lourdes Lopez-Perez; Maria Nicolas Benticuaga
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

5.  Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis.

Authors:  A Mussi; C Bonifati; M Carducci; G D'Agosto; F Pimpinelli; D D'Urso; L D'Auria; M Fazio; F Ameglio
Journal:  J Biol Regul Homeost Agents       Date:  1997 Jul-Sep       Impact factor: 1.711

6.  Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis.

Authors:  Matthew J Loza; Carrie Brodmerkel; Roland M Du Bois; Marc A Judson; Ulrich Costabel; Marjolein Drent; Mani Kavuru; Susan Flavin; Kim Hung Lo; Elliot S Barnathan; Robert P Baughman
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

Review 7.  Pathogenesis and therapy of psoriasis.

Authors:  Michelle A Lowes; Anne M Bowcock; James G Krueger
Journal:  Nature       Date:  2007-02-22       Impact factor: 49.962

Review 8.  Chronic cutaneous lesions of sarcoidosis.

Authors:  Richard M Marchell; Marc A Judson
Journal:  Clin Dermatol       Date:  2007 May-Jun       Impact factor: 3.541

9.  Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients.

Authors:  Halil Yanardağ; Omer Nuri Pamuk; Tuncer Karayel
Journal:  Respir Med       Date:  2003-08       Impact factor: 3.415

10.  Infliximab therapy for sarcoidosis (lupus pernio).

Authors:  H Haley; W Cantrell; K Smith
Journal:  Br J Dermatol       Date:  2004-01       Impact factor: 9.302

View more
  1 in total

1.  Verrucous plaques on the elbows.

Authors:  Paul M Hoesly; Mario M Mitkov; Mark A Cappel
Journal:  JAAD Case Rep       Date:  2019-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.